Aslam Ejaz - Assistant Professor ...

Dr. Aslam Ejaz, MD

Claim this profile

Ohio State University Comprehensive Cancer Center

Studies Pancreatic Cancer
Studies Liver Cancer
6 reported clinical trials
14 drugs studied

Affiliated Hospitals

Image of trial facility.
Ohio State University Comprehensive Cancer Center
Image of trial facility.
University Of Illinois

Clinical Trials Aslam Ejaz, MD is currently running

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria
Image of trial facility.

Ablative Therapy + Systemic Therapy

for Colorectal Cancer

This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients who are not participating in a study is treatment with intravenous (IV) (through a vein) and/or oral medications (systemic therapy) to help stop the cancer sites from getting larger and the spread of the cancer to additional body sites. Ablative means that the intention of the local treatment is to eliminate the cancer at that metastatic site. The ablative local therapy will consist of very focused, intensive radiotherapy called stereotactic ablative radiotherapy (SABR) with or without surgical resection and/or microwave ablation, which is a procedure where a needle is temporarily inserted in the tumor and heat is used to destroy the cancer cells. SABR, surgical resection, and microwave ablation have been tested for safety, but it is not scientifically proven that the addition of these treatments are beneficial for your stage of cancer. The addition of ablative local therapy to all known metastatic sites to the usual approach of systemic therapy could shrink or remove the tumor(s) or prevent the tumor(s) from returning.
Recruiting2 awards Phase 3

More about Aslam Ejaz, MD

Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Aslam Ejaz, MD has experience with
  • Questionnaire Administration
  • Resection
  • Best Practice
  • Exercise Intervention
  • Physical Therapy
  • Anesthesia Procedure

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Aslam Ejaz, MD specialize in?
Is Aslam Ejaz, MD currently recruiting for clinical trials?
Are there any treatments that Aslam Ejaz, MD has studied deeply?
What is the best way to schedule an appointment with Aslam Ejaz, MD?
What is the office address of Aslam Ejaz, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security